GlassScriptPhysician profile
Jorge Luis Ramirez
NPI 1902149461
$4,314.41
in general payments reported to CMS, 2019-2025
7 companies · $457 in 2025
The $457 reported for 2025 was more than what 81% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,136 · 2020: $266 · 2021: $328 · 2022: $567 · 2023: $1,109 · 2024: $452 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $245 · Education: $167 · Gift: $91.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $245.17 |
| Education | $167.18 |
| Gift | $91.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,194.69 | 2019-2025 | |
| Salvin Dental Specialties, INC. | $521.05 | 2019-2021 | |
| Biohorizons Implant Systems INC. | $256.09 | 2019-2024 | Biohorizons |
| Geistlich Pharma, North America, INC. | $125.24 | 2019-2021 | |
| Nobel Biocare USA | $111.46 | 2019-2023 | Nobelactive |
| Zimvie INC. | $83.30 | 2023-2024 | |
| Envista Holdings Corporation | $22.58 | 2025 | Maxcem Elite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.